WARNING: This product is for research use only, not for human or veterinary use.
Hodoodo CAT#: H471133
CAS#: NONE
Description: ELOVL1-22 is a novel highly potent, selective, and CNS-penetrant inhibitor of ELOVL fatty acid elongase 1 (ELOVL1).
Hodoodo Cat#: H471133
Name: ELOVL1-22
CAS#: NONE
Chemical Formula: C21H23N5O2
Exact Mass: 377.19
Molecular Weight: 377.450
Elemental Analysis: C, 66.83; H, 6.14; N, 18.55; O, 8.48
Synonym: ELOVL1-22, ELOVL1 22, ELOVL1 inhibitor 22
IUPAC/Chemical Name: (S)-4-(6-((1s,3R)-3-(1H-pyrazol-1-yl)cyclobutoxy)pyrimidin-4-yl)-2-phenylmorpholine
InChi Key: JXGFJBHPOCYADP-CEXWTWQISA-N
InChi Code: InChI=1S/C21H23N5O2/c1-2-5-16(6-3-1)19-14-25(9-10-27-19)20-13-21(23-15-22-20)28-18-11-17(12-18)26-8-4-7-24-26/h1-8,13,15,17-19H,9-12,14H2/t17-,18+,19-/m1/s1
SMILES Code: N1(C2=NC=NC(O[C@H]3C[C@@H](N4N=CC=C4)C3)=C2)C[C@H](C5=CC=CC=C5)OCC1
Appearance: Solid powder
Purity: >98% (or refer to the Certificate of Analysis)
Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility: To be determined
Shelf Life: >2 years if stored properly
Drug Formulation: To be determined
Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code: 2934.99.9001
More Info:
| Biological target: | |
| In vitro activity: | |
| In vivo activity: |
| Solvent | Max Conc. mg/mL | Max Conc. mM | |
|---|---|---|---|
| Solubility | |||
| Ethanol | 25.0 | 66.24 |
The following data is based on the product molecular weight 377.45 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
|---|---|---|---|
| 1 mM | 1.15 mL | 5.76 mL | 11.51 mL |
| 5 mM | 0.23 mL | 1.15 mL | 2.3 mL |
| 10 mM | 0.12 mL | 0.58 mL | 1.15 mL |
| 50 mM | 0.02 mL | 0.12 mL | 0.23 mL |
| Formulation protocol: | |
| In vitro protocol: | |
| In vivo protocol: |
